Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, November 18, 2020
Stelis BioSource has started the next phase of its continued investment program.
read more
Wednesday, February 25, 2026
SteinCares and Shilpa Biologicals announced a strategic licensing agreement to commercialize a biosimilar across Latin America.
read more
Tuesday, January 05, 2021
Stäubli has announced a new Chief Executive Officer.
read more
Monday, December 17, 2018
Staten Biotechnology and Novo Nordisk have entered into a collaboration and exclusive option agreement to develop novel therapeutics for the treatment of hypertriglyceridaemia.
read more
Thursday, December 27, 2018
The day before a planned Georgia General Assembly House study committee meeting, the Kratom Trade Association said it is reaching out to state lawmakers to directly resolve their concerns about kratom.
read more
Friday, February 22, 2019
Assessing and mitigating risks is at the heart of everything we do across our vast portfolio.
read more
Today, we’re taking a key step forward in implementing the Drug Quality and Security Act (DQSA) and section 503B of the Federal Food, Drug, and Cosmetic Act.
read more
Thursday, February 14, 2019
The opioid epidemic continues to be one of the greatest challenges facing this nation and the FDA.
read more
Wednesday, February 14, 2018
Additional resources will help advance initiatives to support novel medical technology and public health priorities such as generic drug development, pharmacy outsourcing and novel domestic manufacturing capabilities.
read more
Wednesday, September 05, 2018
Over the past 25 years, globalization of drug manufacturing has prompted the FDA to change its regulatory landscape.
read more
We’ve long recognized that compounded drugs can serve an important role for patients whose medical needs cannot be met by an FDA-approved drug product.
read more
Friday, November 17, 2017
Update on the efforts by the FDA to address IV fluid shortages exacerbated by Hurricane Maria and advice for hospitals in managing the shortage.
read more
Friday, December 01, 2017
At the FDA, we’re vigilant about helping address the challenges that remain.
read more
We’ve seen the number of new drug shortages steadily decline since a peak in 2011 owing to the work of the FDA, industry and other groups.
read more
As part of our public health mission, the FDA monitors the pharmaceutical supply chain to support patient access to medically necessary drugs.
read more